CODE_02.png

Code Pharma   

Code Pharma is a global pharmaceutical company with knowledgeable and experienced staff, committed and dedicated in the field of viral infections, AIDS and Cancer research.We aim to bring to the market a cost-effective treatment based on findings from extensive research to the entire target demographic irrelevant of income or status.Our ground-breaking research and patent protected findings are the basis of a new era of fighting against infectious and oncological diseases.

Antiviral drug Codivir

Code Pharma is the developer of the promising antiviral drug Codivir against COVID-19. Codivir is a short synthetic 16 amino-acid peptide, derived from the HIV-1 integrase, originally discovered at the Hebrew University in Israel.

Code Pharma's team discovered that the peptide had a direct antiviral effect against SARS-CoV-2, the coronavirus causing COVID-19.In-vitro studies conducted at the British research laboratory Virology Research Services then demonstrated a potent antiviral activity against SARS-CoV-2 and other RNA viruses.

coode btl.png

Clinical studies

Codivir is a short synthetic peptide derived from HIV virus that was found in preclinical and clinical examinations to either:

1. Leads to antiviral effect against RNA viruses.

2. Promote HIV-infected cells into self-induced death (apoptosis), and Lentivirus manipulation in the case of cancer therapy.

image2.png
 

Our Partners

Artboard 1 copy 3.png
Artboard 1.png
Artboard 1 copy.png
Artboard 1 copy 2.png

    Contact    

Thanks for submitting!